supported by the National Institute on Drug Abuse

The NIDA-AACAP Resident Training Award in Substance Abuse and Addiction, supported by the National Institute on Drug Abuse, seeks to facilitate the dissemination of research-based treatment by general psychiatry and child and adolescent psychiatry residents in treatment settings. By providing up to two awards to residents for training programs, we support these young investigators at a critical stage, encouraging future careers in substance abuse and addiction research.

For early investigators, obtaining funding for training and mentored experiences is critical, but it is also the most difficult to secure. The NIDA-AACAP Training Award provides up to one year of support to general and child and adolescent psychiatry residents to support training in research. Through support from this program, the awardee(s) will:

  • Conduct a project including secondary data or analyses;
  • Develop an abstract for a scientific poster presentation at the 64th AACAP Annual Meeting in 2017; and
  • Develop a submission of a manuscript for publication in a peer-reviewed journal.

This award does not support new, free-standing pilot studies, clinical trials, or clinical research studies.

The award offers up to $10,000 for program support (award amount includes travel to AACAP's 64th Annual Meeting in Washington, DC, October 23-28, 2017; and travel to the NIDA Clinical Trials Network's Steering Committee meeting in spring 2017) and $1,500 for a mentor stipend. (All awards are contingent upon the receipt of adequate funding support.)

INSTRUCTIONS FOR APPLICATION SUBMISSION

Please submit the following required items to Lisell Perez-Rogers, Coordinator, Research and Training at lrogers@aacap.org by 11:00 pm EST on Friday, October 7, 2016. Note: All letters submitted electronically must contain valid signatures.

Instructions for Application Submission

  • Completed award application.
  • A proposal, of no more than five pages (single spaced, no less than 12 pt. font and 1'' margins), to include the following:
    • Candidate section, including a brief description of background and interest in the substance abuse and addiction field.
    • Planned activities including full details on significance and specific aims, goals, background, rationale, and an implementation and dissemination plan
    • A detailed activity/project timeline with tentative dates of all activities for the proposed project
    • A budget and justification containing sufficient detail so that each item can be judged separately. Computer related items (e.g., personal computers, printers, modems, etc.) are extremely unlikely to receive budget approval. Salary support will not be provided to the mentor. No indirect costs to the institution will be provided. Typical budget items may include but are not limited to, honoraria, travel expenses, etc.
  • A letter detailing any current and/or previous funding
  • Applicant’s current curriculum vitae
  • A letter of support from the proposed mentor, including a descriptive support of awardee and a brief description on how he/she will play a key role in shaping and assisting the candidate in fulfilling the needs of this award.
  • A letter of support from residency training director indicating/confirming time available for activities

RECOMMEND ACTIVITIES

This award cannot support new, free-standing pilot studies, clinical trials, or clinical research studies. Projects should focus on improving dissemination of treatment research and/or facilitating implementation of evidence-based practices. The goal of this award to provide opportunities to enhance knowledge of SUD and SUD treatment, to promote dissemination of substance use disorder research findings, and to promote the adoption of evidence-based approaches in clinical settings.

Examples of appropriate activities and projects include but are not limited to:

  • Analysis of de-identified data from completed clinical trials such as those found on the NIDA Data Share website (https://datashare.nida.nih.gov/) to inform dissemination or implementation efforts;
  • Analysis of de-identified data from electronic health records or registries such as the ACEP Clinical Emergency Data Registry (https://www.acep.org/cedr/) to characterize availability of data on substance use or practice patterns, identify gaps in the provision of evidence-based practices, and/or identify needs for dissemination or implementation.
  • Reviewing available curricula or training programs, identifying status of education on SUD diagnosis and treatment in various settings, and proposing and conducting activities to improve training;
  • Identifying best practices or effective strategies or models for SUD education;
  • Developing materials that could be used for quality improvement or integration of an evidence-based approach or process in a medical setting and conducting activities for quality improvement or adoption;
  • Identifying training gaps and research findings and/or NIDA products that could bridge gaps, identifying potential partners for effective dissemination of these findings and disseminating them within existing or newly developed communication channels;
  • Coursework to strengthen formal training in substance use disorder research and;
  • Other activities consistent with the goals of the Blending Initiative to accelerate the dissemination of research findings and implementation or adoption of evidence-based SUD treatment in clinical practice.

RECOMMENDED CLINICAL TOPIC AREAS

Proposals must include components of child and adolescent substance abuse and/or addiction treatment research. Recommended topic areas include:

  • Screening and brief intervention for adolescents misusing marijuana, tobacco, alcohol and other drugs including prescription medications;
  • Smoking cessation for adolescent patients in the medical or behavioral healthcare system;
  • Integrating substance abuse treatment for youth with(in) primary care or a medical home;
  • Integration or augmentation of electronic health records to include substance abuse and addiction disorders for youth;
  • Prescription drug abuse in youth;
  • Co-occurring disorders in youth; or
  • Screening and management of HIV/Hepatitis/STD infections in adolescent patients with substance abuse and addiction disorders.

AACAP will consider additional research topics that meet the criteria of direct relevance to child and adolescent substance abuse and/or addiction treatment research and dissemination. For consideration of a topic not listed above, applicants must contact Carmen J. Head, MPH, AACAP Director of Research, Training, and Education at chead@aacap.org to discuss his/her topic before submitting an application.

AWARD REQUIREMENTS

  • Applicants must be enrolled in a psychiatry, child psychiatry, or triple board program and be at the PGY2 level or higher.
  • Applicants must be enrolled a fully accredited general psychiatry or child and adolescent psychiatry clinical research or training program.
  • Applicants must have a mentor who has had experience in substance use disorder treatment and/or research. It is preferred that the mentor's work include children and adolescents. The mentor does not need to be a child psychiatrist by training.
  • Candidates must not have any current or previous significant, individual research funding in the field of child and adolescent mental health. Candidates should not have had previous or simultaneous funding from the National Institutes of Health (NIH) or other research funding sources. Eligible candidates will not have a career development award.
  • Applicants must either be AACAP members or have a membership application pending (not paid by the award) and agree to submit a proposal for a poster presentation on his or her activities or project for AACAP's 64th Annual Meeting, October 23-28, 2017 in Washington, DC.
  • Applicants must agree to attend the NIDA Clinical Trials Network's Steering Committee meeting in spring 2017 (date to be determined) to learn about data sharing opportunities, review grant application processes, and network with other addiction clinicians and researchers.
  • Applications must be submitted via e-mail to Lisell Perez-Rogers at lrogers@aacap.org by 11:00PM EST on Friday, October 7, 2016.
  • All applicants are responsible for ensuring their own adherence to all federal research regulations, certifications and assurances. Institutional agreement of acceptance of their role and responsibility for the oversight of the award and proposed activities will be requested through the application process.
  • Participants agree to participate in all annual surveys as part of the program evaluation process.

REPORTING REQUIREMENTS

  • All award recipients will be required to submit a progress report detailing his/her work in May 2017.
  • All award recipients will be required to submit a presentation on his/her project for the 64th Annual Meeting.

REVIEW PROCESS

Applications will be reviewed by senior investigators with experience in related work in child and adolescent psychiatry research. Prior to the scientific review process, applications will undergo an administrative review process.

  • Administrative Review – Applications will be reviewed for submission of all application materials. Incomplete applications will not be forwarded for further review. Please ensure you meet the eligibility requirements and have submitted all requested application materials before finalizing your application.
  • Selection & Review – Applications will undergo a scientific review process by senior child and adolescent psychiatrists with relevant expertise. Applications will be scored by the NIDA-AACAP Resident Training Award Program Selection Committee. The Selection Committee will prepare written reviews and score all applications. The review criteria are as follows:
    • Strength of the proposed activities or project plan, including conceptual or clinical framework, or secondary data gathering plan, design, methods, and analyses
    • Feasibility of the proposed activities or project to advance scientific knowledge or clinical practice in the field of child and adolescent psychiatry;
    • The applicant's commitment and potential to become a champion of SUD evidence-based treatment in general medical settings and/or career investigator in the SUD field;
    • Endorsement, support, and qualifications of the applicant; and
    • Strength of commitment and support from the applicant's host institution.

AACAP reserves the right to cancel the award if terms and conditions are not met. AACAP maintains the right to waive informalities.

APPLICATION DEADLINE

All completed applications and attachments must be submitted by 11:00 pm EST on Friday, October 7, 2016. Materials should be sent to Lisell Perez-Rogers at lrogers@aacap.org

Availability of all awards is contingent upon the receipt of adequate funding. AACAP has the right to waive informalities.

Last updated: August 2016